References
- Heymann DL, Brilliant L. Surveillance in eradication and elimination of infectious diseases: a progression through the years. Vaccine. 2011;29:D141–4.
- Muyembe-Tamfum JJ, Mulembakani P, Lekie RB, Szczeniowski M, Ježek Z, Doshi R, et al. Smallpox and its eradication in the Democratic Republic of Congo: lessons learned. Vaccine. 2011;29:D13–8.
- Tomori O. From smallpox eradication to the future of global health: innovations, application and lessons for future eradication and control initiatives. Vaccine. 2011;29:D145–8.
- Aylward B, Tangermann R. The global polio eradication initiative: lessons learned and prospects for success. Vaccine. 2011;29:D80–5.
- Grassly NC. The final stages of the global eradication of poliomyelitis. Philos Trans R Soc Lond B Biol Sci. 2013;368:20120140.
- WHO. Poliomyelitis [Internet]. Fact Sheet No. 114. Geneva: WHO; 2013 [cite 2013 Dec 23]. Available from: http://www.who.int/mediacentre/factsheets/fs114/en/
- Nsambu MN, Bazira L, Coulibaly T, Mbule A, Wilmet MD, Likwela JL. Investigation and response to an outbreak of wild poliovirus in Kinshasa. Pan Afr Med J. 2013;15:37.
- Centers for Disease Control and Prevention (CDC). Poliomyelitis outbreak—Republic of the Congo, September 2010–February 2011. MMWR Morb Mortal Wkly Rep. 2011;60:312–3.
- Le Menach A, Llosa AE, Mouniaman-Nara I, Kouassi F, Ngala J, Boxall N, et al. Poliomyelitis outbreak, Pointe-Noire, Republic of the Congo, September 2010–February 2011. Emerg Infect Dis. 2011;17:1506–9.
- Patel MK, Konde MK, Didi-Ngossaki BH, Ndinga E, Yogolelo R, Salla M, et al. An outbreak of wild poliovirus in the Republic of Congo, 2010–2011. Clin Infect Dis. 2012;55:1291–8.
- Organisation mondiale de la santé. Activité d’éradication de la poliomyélite, République Démocratique du Congo. Mise à jour du 22 juillet 2011. Geneva: WHO; 2011.
- Nzolo D, Ntetani Aloni M, Mpiempie Ngamasata T, Mvete Luemba B, Bazundama Marfeza S, Bothale Ekila M, et al. Adverse events following immunization with oral poliovirus in Kinshasa, Democratic Republic of Congo: preliminary results. Pathog Glob Health. 2013;107:381–4.
- WHO. Causality assessment of an adverse event following immunization (AEFI). User manual for the revised WHO classification. Geneva: WHO; 2013.
- Amarasinghe A, Black S, Bonhoeffer J, Carvalho SM, Dodoo A, Eskola J, et al. Effective vaccine safety systems in all countries: a challenge for more equitable access to immunization. Vaccine. 2013;31:B108–14.
- Grassly NC. Immunogenicity and effectiveness of routine immunization with 1 or 2 doses of inactivated poliovirus vaccine: systematic review and meta-analysis. J Infect Dis. 14 March 2014 [Epub ahead of print]. doi 10.1093/infdis/jit601
- World Health Organization, Department of Vaccines and Biologicals. Supplementary information on vaccine safety; Part 2: Background rates of adverse events following immunization. Geneva: WHO; 2000.
- World Health Organization, Department of Vaccines and Biologicals. Supplementary information on vaccine safety; Part 1: Field issue. Geneva: WHO; 2000
- Pal SN, Duncombe C, Falzon D, Olsson S. WHO strategy for collecting safety data in public health programmes: complementing spontaneous reporting systems. Drug Saf. 2013;36:75–81.
- Budhiraja S, Akinapelli R. Pharmacovigilance in vaccines. Indian J Pharmacol. 2010;42:117.
- Parrella A, Braunack-Mayer A, Gold M, Marshall H, Baghurst P. Healthcare providers’ knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative study. BMC Health Serv Res. 2013;13:313.